Biotech ends summer on a high

Biotech finished on a high in August, according to San Francisco venture capital firm Burrill & Company.

The company’s Burrill Biotech Select Index closed up 4.4 percent on Friday before the Labor Day holiday weekend, said G. Steven Burrill, company CEO.

Top performers included Emeryville’s Onyx Pharmaceuticals (ONXX), up 42 percent, and Vertex Pharmaceuticals, up 21 percent.

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/
Previous story
Oracle to acquire Ireland's Netsure
Next story
Business briefs: 'Second Life' crisis

Just Posted

Chinatown fixture Yuet Lee prepares for New Year with new leadership in the kitchen

Although Chinese New Year is a holiday, at newly anointed legacy business… Continue reading

Miss Chinatown USA pageant first step to successful careers for San Francisco sisters

Local contest opened doors for women in Chinese community when they were barred from other events

Calendar of Events: San Francisco celebrates the Year of the Rat

JAN. 25 Choy Sun Doe Day: The San Francisco Chinese Chamber of… Continue reading

From auto burglaries to homicides, crime fell in San Francisco in 2019

In the face of national scrutiny over street conditions in San Francisco,… Continue reading

The 29-Sunset could become a ‘rapid’ route

Muni weighing change after Lowell students advocated for improved service on line

Most Read